PharmaShots Weekly Snapshot (Jun 15-19, 2020)

 1.  Ultragenyx and Kyowa Kirin’s Crysvita (burosumab) Receive the US FDA’s Approval for the Treatment of Tumor-Induced Osteomalacia 

Published: Jun 19, 2020 | Tags: Ultragenyx, Kyowa Kirin, Crysvita, burosumab, Receives, US, FDA, Approval, Treatment, Tumor-Induced Osteomalacia

2.  Pfizer and Sangamo’s Giroctocogene Fitelparvovec (SB-525) Demonstrate Positive Effect in P-I/II Alta Study for Hemophilia A

Published: Jun 18, 2020 | Tags: Pfizer, Sangamo, SB-525, Demonstrate, Positive Effect, P-I/II Alta, Study, Hemophilia A

 3. Innovent Receives the NMPA’s Approval for Byvasda (biosimilar, bevacizumab) to Treat Non-Small Cell Lung Cancer and Metastatic Colorectal Cancer in China

Published: Jun 19, 2020 | Tags: Innovent, Receives, NMPA, Approval, Byvasda, biosimilar, bevacizumab, Treat, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, China

4.  RedHill Expands its P-II/III Study Evaluating Yeliva (opaganib) Against COVID-19 in Italy and UK

Published: Jun 18, 2020 | Tags: RedHill, Expands, P-II/III, Study, Evaluating, Yeliva, opaganib, Against, COVID-19, Italy, UK

5. Roche and Cipla Expand Their 2018 Agreement to Improve Access of Oncology Therapies in India

Published: Jun 18, 2020 | Tags: Roche, Cipla, Expand, Their, 2018 Agreement, Improve, Access, Oncology Therapies, India

6.  AbbVie Signs an Exclusive Worldwide Option and License Agreement with Alpine to Develop and Commercialize ALPN-101

Published: Jun 18, 2020 | Tags: AbbVie, Signs, Exclusive, Worldwide, Option, License Agreement, Alpine, Develop, Commercialize ALPN-101

7.  PRA Collaborates with Microsoft to Foster COVID-19 Monitoring

Published: Jun 12, 2020 | Tags: PRA, Collaborates, Microsoft, Foster, COVID-19, Monitoring

8.  Merck’s Keytruda (pembrolizumab) Receives the US FDA’s Approval as Monotherapy for Patients with Unresectable or Metastatic Tumor Mutational Burden-High Solid Tumors

Published: Jun 17, 2020 | Tags: Merck, Keytruda, pembrolizumab, Receives, US, FDA, Approval, Monotherapy, Patients, Unresectable, Metastatic, Tumor, Mutational, Burden-High Solid Tumors

9. AstraZeneca Collaborates with Gendius to Provide Diabetes Management Support for Patients in the GCC

Published: Jun 17, 2020 | Tags: AstraZeneca, Collaborates, Gendius, Provide, Diabetes Management Support, Patients, GCC

10.  Samsung Launches a Blood Pressure Monitoring App in South Korea

Published: Jun 18, 2020 | Tags:  Samsung, Launches, Blood Pressure, Monitoring App, South Korea

11.  Roche Reports Results of Tecentriq + CT in P-III IMpassion031 Study for Patients with Early Triple-Negative Breast Cancer

Published: Jun 18, 2020 | Tags: Roche, Reports, Results, Tecentriq + CT, P-III, IMpassion031, Study, Patients, Early Triple-Negative Breast Cancer

12.  Gilead to Initiate P-II/III Study Evaluating Remdesivir in Pediatric Patients Hospitalized With COVID-19

Published: Jun 17, 2020 | Tags: Gilead, Initiate, P-II/III, Study, Evaluating, Remdesivir, Pediatric Patients, Hospitalized, COVID-19

13.  AstraZeneca Signs an Agreement with Cobra Biologics for Vaccines Against COVID-19

Published: Jun 16, 2020 | Tags: AstraZeneca, Signs, Agreement, Cobra Biologics, Vaccines, Against, COVID-19

14.   Novartis’ Cosentyx (secukinumab) Receives the US FDA’s Approval for Active Non-Radiographic Axial Spondyloarthritis

Published: Jun 17, 2020 | Tags: Novartis, Cosentyx, secukinumab, Receives, US, FDA, Approval, Active, Non-Radiographic Axial Spondyloarthritis

15.   Merck and Pfizer Report Results of Steglatro (ertugliflozin) in P-III VERTIS CV Study for Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

Published: Jun 17, 2020 | Tags: Merck, Pfizer, Report, Results, Steglatro, ertugliflozin, P-III, VERTIS CV, Study, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease

16.   Takeda Signs an Exclusive License and Research Agreement with Debiopharm to Develop Novel Microbiome Therapeutics for the Gastrointestinal Disorders

Published: Jun 17, 2020 | Tags: Takeda, Signs, Exclusive, License, Research Agreement, Debiopharm, Develop, Novel Microbiome Therapies, Gastrointestinal Disorders

17. Sanofi Report Results of Avalglucosidase alfa in P-III COMET Study for Late Onset Pompe Disease

Published: Jun 17, 2020 | Tags: Sanofi, Reports, Results, Avalglucosidase alfa, P-III, COMET Study, Late Onset Pompe Disease

18.  GSK Signs a Synthetic Lethality Cancer Agreement with Ideaya for ~$170M

Published: Jun 16, 2020 | Tags: GSK, Signs, Synthetic Lethality Cancer, Agreement, Ideaya, $170M

19.  Takeda and Neurocrine Collaborate for Seven Neuro Programs Worth Up to $2B

Published: Jun 17, 2020 | Tags: Takeda, Neurocrine, Collaborate, Seven, Neuro Programs, Worth Up to, $2B

20.   Sun Pharma Signs a License Agreement with Hikma for Ilumya (tildrakizumab) in MENA Regions

Published: Jun 15, 2020 | Tags: Sun Pharma, Signs, License Agreement, Hikma, Ilumya, tildrakizumab, MENA Regions

21. Celltrion Report Results of Truxima (biosimilar, rituximab) Based Regimen in P-II Study for R/R Aggressive B-cell Lymphoma #EHA25

Published: Jun 16, 2020 | Tags: Celltrion, Report, Results, Truxima, biosimilar, rituximab, Based, Regimen, P-II, Study, R/R, Aggressive, B-cell Lymphoma, #EHA25

22.  Bayer and MassBio to Launch Joint Mentoring Program to Foster Startups in Asia

Published: Jun 15, 2020 | Tags: Bayer, MassBio, Launch, Joint Mentoring Program, Foster, Startups, Asia

23.  Celltrion Anticipates the Launch of its POCT Kit for COVID-19 in July 2020

Published: Jun 15, 2020 | Tags: Celltrion, Anticipates, Launch, POCT Kit, COVID-19, July, 2020

24.  Akili’s EndeavorRx Receives the US FDA’s Approval as the First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD

Published: Jun 15, 2020 | Tags:  Akili, EndeavorRx, Receives, US, FDA, Approval, First, Game-Based, Digital Therapeutic, Improve, Attention, Function, Children, ADHD

25.  AstraZeneca Signs an Agreement with Catalent to Manufacture AZD1222 for COVID-19

Published: Jun 15, 2020 | Tags: AstraZeneca, Signs, Agreement, Catalent, Manufacture, AZD1222, COVID-19

26.  Foundation Medicine Acquires Lexent to Expand its Liquid Biopsy Platforms

Published: Jun 14, 2020 | Tags: Foundation Medicine, Acquires, Lexent, Expand, Liquid Biopsy Platforms

27. Merck’s Gardasil 9 Receives the US FDA’s Approval to Prevent HPV-Related Head and Neck Cancers

Published: Jun 15, 2020 | Tags: Merck, Gardasil 9, Receives, US, FDA, Approval, Prevent, HPV-Related, Head and Neck Cancers

28. Eli Lilly Initiates P-III Study Evaluating Baricitinib in Hospitalized Patients with COVID-19

Published: Jun 14, 2020 | Tags: Eli Lilly, Initiates, P-III, Study, Evaluating, Baricitinib, Hospitalized, Patients, COVID-19

29.   Gilead Signs a License Agreement with Zydus and Dr. Reddy’s for Remdesivir to Treat COVID-19

Published: Jun 14, 2020 | Tags: Gilead, Signs, License Agreement, Zydus, Dr. Reddy’s, Remdesivir, Treat, COVID-19

30.  AstraZeneca To Supply 400M Doses of Vaccines to IVA by the End of 2020

Published: Jun 14, 2020 | Tags: AstraZeneca, Supply, 400M, Doses, Vaccines, IVA, End, 2020

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post